{
    "title": "Drug that caused \"elephant man\" side effect makes comeback after 2006 disaster",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3009519/Drug-caused-elephant-man-effect-makes-comeback-2006-disaster.html",
    "date": "2015-03-24",
    "keywords": [
        "drug",
        "trial",
        "way",
        "side",
        "disaster",
        "march",
        "company",
        "test",
        "system",
        "man",
        "comeback",
        "gmt",
        "arthritis",
        "biotech",
        "midstage",
        "june",
        "chief",
        "executive",
        "london",
        "theramab",
        "russia",
        "journal",
        "none",
        "treatment",
        "tyrsin",
        "phase",
        "approval",
        "tab08",
        "industry",
        "effect",
        "email",
        "ben",
        "promise",
        "fraction",
        "dosethe",
        "firm",
        "investor",
        "reutersit",
        "turnaround",
        "care",
        "head",
        "collapse",
        "germanys",
        "developer",
        "medicine",
        "tgn1412since",
        "tube",
        "calculation",
        "starting",
        "dosethat",
        "llc",
        "startup",
        "germany",
        "fund",
        "bioprocess",
        "capital",
        "editorial",
        "edition",
        "pharmacology",
        "tab08s",
        "return",
        "course",
        "couple",
        "tegenero",
        "money",
        "editor",
        "cohen",
        "university",
        "laterstage",
        "treatmentsbut",
        "story",
        "thalidomide",
        "birth",
        "century",
        "morning",
        "sickness",
        "pregnancy",
        "blood",
        "pitfalltheramab",
        "dmitry",
        "interview",
        "project",
        "pharma",
        "deal",
        "year",
        "autoimmune",
        "cd28",
        "superagonist",
        "immune",
        "antibody",
        "rheumatoid",
        "risk",
        "overstimulation",
        "cynomolgus",
        "differencesnow",
        "study",
        "benefit",
        "highrisk",
        "success",
        "product"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}